Literature DB >> 23477429

Geographical patterns in the recreation and leisure participation of children and youth with cerebral palsy: a CAPE international collaborative network study.

Gillian King1, Christine Imms, Robert Palisano, Annette Majnemer, Lisa Chiarello, Margo Orlin, Mary Law, Lisa Avery.   

Abstract

PURPOSE: To examine geographical variation in the leisure participation of children/youth with cerebral palsy (CP), using Children's Assessment of Participation and Enjoyment (CAPE) data from Australia, Canada (Ontario and Quebec) and the U.S.
METHOD: Data from 1076 children/youth ages 6-20 years with CP were included. Analyses examined CAPE diversity scores in activity types as a function of region, age group and Gross Motor Function Classification System (GMFCS) group, controlling for family income, education and child gender.
RESULTS: There were only two substantial geographical differences: children/youth from the U.S. took part in the fewest active physical activities; those from Ontario took part in the most self-improvement activities. The youngest age group took part in the most recreational activities, and those in GMFCS level IV/V had the lowest levels of participation in recreational, active physical and self-improvement activities, confirming previous findings.
CONCLUSIONS: There were more similarities than differences in participation patterns for the three countries.

Entities:  

Mesh:

Year:  2013        PMID: 23477429     DOI: 10.3109/17518423.2013.773102

Source DB:  PubMed          Journal:  Dev Neurorehabil        ISSN: 1751-8423            Impact factor:   2.308


  2 in total

1.  Mental health problems in children with neuromotor disabilities.

Authors:  Benjamin Klein
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

2.  A descriptive study of the participation of children and adolescents in activities outside school.

Authors:  Christine Imms; Elspeth Froude; Brooke Adair; Nora Shields
Journal:  BMC Pediatr       Date:  2016-07-08       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.